Annual Drug Patent Expirations for SPIRIVA+RESPIMAT
Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
SPIRIVA RESPIMAT drug price trends.
The generic ingredient in SPIRIVA RESPIMAT is tiotropium bromide. One supplier is listed for this compound. Additional details are available on the tiotropium bromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
